Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Work In Process (2016 - 2025)

Amphastar Pharmaceuticals has reported Work In Process over the past 11 years, most recently at $40.4 million for Q4 2025.

  • Quarterly results put Work In Process at $40.4 million for Q4 2025, up 23.27% from a year ago — trailing twelve months through Dec 2025 was $40.4 million (up 23.27% YoY), and the annual figure for FY2025 was $40.4 million, up 23.27%.
  • Work In Process for Q4 2025 was $40.4 million at Amphastar Pharmaceuticals, down from $42.5 million in the prior quarter.
  • Over the last five years, Work In Process for AMPH hit a ceiling of $43.8 million in Q1 2025 and a floor of $28.3 million in Q3 2023.
  • Median Work In Process over the past 5 years was $36.6 million (2022), compared with a mean of $36.5 million.
  • Biggest five-year swings in Work In Process: fell 26.63% in 2023 and later soared 31.34% in 2025.
  • Amphastar Pharmaceuticals' Work In Process stood at $33.3 million in 2021, then rose by 11.39% to $37.1 million in 2022, then fell by 16.9% to $30.8 million in 2023, then grew by 6.44% to $32.8 million in 2024, then grew by 23.27% to $40.4 million in 2025.
  • The last three reported values for Work In Process were $40.4 million (Q4 2025), $42.5 million (Q3 2025), and $43.6 million (Q2 2025) per Business Quant data.